Silvan Tuerkcan
Stock Analyst at JMP Securities
(1.08)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EXEL Exelixis | Reiterates: Market Outperform | 50 50 | 37.43 | 33.58% | 23 | Jul 29, 2025 | |
JSPR Jasper Therapeutics | Maintains: Market Outperform | 70 12 | 2.62 | 358.02% | 6 | Jul 8, 2025 | |
CRSP CRISPR Therapeutics | Reiterates: Market Outperform | 86 86 | 55.44 | 55.12% | 16 | Jun 27, 2025 | |
NUVB Nuvation Bio | Reiterates: Market Outperform | 6 6 | 2.23 | 169.06% | 3 | Jun 25, 2025 | |
ELEV Elevation Oncology | Reiterates: Market Perform | n/a | n/a | n/a | 9 | Jun 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | 6.06 | 147.52% | 3 | Jun 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 5 6 | 2.75 | 118.18% | 13 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 10 6 | 3.51 | 70.94% | 3 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 4.69 | 91.9% | 3 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 20 20 | 11.91 | 67.93% | 12 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 6 6 | 1.99 | 201.51% | 12 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 3.71 | 385.18% | 4 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 20 20 | 6.3 | 217.46% | 12 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 17 17 | 1.22 | 1293.44% | 5 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 8 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 4 | 0.68 | 488.24% | 1 | Jan 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 21 21 | 3.24 | 548.15% | 10 | Dec 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 12 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 6 6 | 2.64 | 127.27% | 6 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 240 280 | 174.02 | 60.9% | 3 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 9 | Oct 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 18 18 | 9.75 | 84.62% | 1 | Jan 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 10 | Jan 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 2 3 | 7.5 | -60% | 3 | May 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Oct 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Sep 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 200 210 | 228.74 | -8.19% | 8 | Jun 30, 2020 |